Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternative Dosing Regimens in Insomnia (ALPHASOM)
NCT02139098Phase 3Terminated
- Sponsor
- Philipps-Universität Marburg
- Start
- May 2014
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amitriptyline, zolpidem sublingual tablet in Insomnia, sponsored by Philipps-Universität Marburg. Started May 2014; status: terminated.
02
Drugs
amitriptylinezolpidem sublingual tablet
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02139098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02139098.